Long-Term Oral Administration of Piceatannol (3,5,3′,4′-Tetrahydroxystilbene) Attenuates Colon Tumor Growth Induced by Azoxymethane Plus Dextran Sulfate Sodium in C57BL/6J Mice

References

• Siegel RI, Miller KD, Jemal A. Cancer statistics, 2020. CA A Cancer J Clin. 2020;70(1):7–30. doi:10.3322/caac.21590
   PubMed Web of Science ®Google Scholar
• The reports of National Cancer Center, Center for Cancer Control and Information Services, Division of cancer Statistics and Integration, 2019 (Japan). http://ganjoho.jp/reg_stat/statistics/stat/summary.html.
   Google Scholar
• Kimura Y, Okuda H. Effects of naturally occurring stilbene glucosides from medicinal plants and wine, on tumour growth and lung metastasis in Lewis lung carcinoma-bearing mice. J Pharm Pharmacol. 2000;52(10):1287–95. doi:10.1211/0022357001777270
   PubMed Web of Science ®Google Scholar
• Kimura Y, Baba K, Okuda H. Inhibitory effects of active substances isolated from Cassia garrettiana heartwood on tumor growth and lung metastasis in Lewis lung carcinoma-bearing mice (part 1). Anticancer Res. 2000;20(5A):2899–906.
   PubMedGoogle Scholar
• Kimura Y, Baba K, Okuda H. Inhibitory effects of active substances from Cassia garrettiana heartwood on tumor growth and lung metastasis in Lewis lung carcinoma-bearing mice (part 2). Anticancer Res. 2000;20(5A):2923–30.
   PubMedGoogle Scholar
• Kimura Y, Okuda H. Resveratrol isolated from Polygonum cuspidatum root prevents tumor growth and metastasis to lung and tumor-induced neovascularization in Lewis lung carcinoma-bearing mice. J Nutr. 2001;131(6):1844–9. doi:10.1093/jn/131.6.1844
   PubMedGoogle Scholar
• Kimura Y, Sumiyoshi M, Baba K. Antitumor activities of synthetic and natural stilbenes through antiangiogenic action. Cancer Sci. 2008;99(10):2083–94. doi:10.1111/j.1349-7006.2008.00948.x
   PubMedGoogle Scholar
• Kimura Y, Sumiyoshi M, Baba K. Antitumor and antimetastatic activity of synthetic hydroxystilbenes through the inhibition of lymphangiogenesis and M2 macrophage differentiation of tumor-associated macrophages. Anticancer Res. 2016;36(1):137–48.
   PubMedGoogle Scholar
• Kimura Y, Sumiyoshi M. Resveratrol prevents tumor growth and metastasis by inhibiting lymphangiogenesis and M2 macrophage activation and differentiation in tumor-associated macrophages. Nutr Cancer. 2016;68(4):667–78. doi:10.1080/01635581.2016.1158295
   PubMed Web of Science ®Google Scholar
• Kimura Y, Sumiyoshi M, Kiyoi T, Baba K. Dihydroxystilbenes prevent azoxymethane/dextran sulfate sodium-induced colon cancer by inhibiting colon cytokines, a chemokine, and programmed cell death-1 in C57BL/6J mice. Eur J Pharmacol. 2020;886:173445. doi: 10.1016/j.ejphar.20.173445.
   PubMedGoogle Scholar
• Kim YH, Kwon H-S, Kim DH, Cho HJ, Lee HS, Jun J-G, Park JHY, Kim J-K. Piceatannol, a stilbene present in grapes, attenuates dextran sulfate sodium-induced colitis. Int Immunopharmacol. 2008;8(12):1695–702. doi:10.1016/j.intimp.2008.08.003
   PubMed Web of Science ®Google Scholar
• Moriasi C, Subramaniam D, Awasthi S, Anant S, Ramalingam S. Prevention of colitis-associated cancer: natural compounds that target the IL-6 soluble receptor. Anticancer Agents Med Chem. 2012;12(10):1221–38. doi:10.2174/187152012803833080
   PubMed Web of Science ®Google Scholar
• Youn J, Lee J-S, Na H-K, Kundu JK, Surh Y-J. Resveratrol and piceatannol inhibit iNOS expression and NF-kappaB activation in dextran sulfate sodium-induced mouse colitis Nutr Cancer. 2009;61(6):847–54. doi:10.1080/01635580903285072
   PubMed Web of Science ®Google Scholar
• Yum S, Jeong S, Lee S, Nam J, Kim W, Yoo J-W, Kim M-S, Lee BL, Jung Y. Colon-targeted delivery of piceatannol enhances anti-colitic effects of the natural product: potential molecular mechanisms for therapeutic enhancement. Drug Des Devel Ther. 2015;9:4247–58. doi:10.2147/DDDT.S88670
   PubMed Web of Science ®Google Scholar
• Kita Y, Miura Y, Yagasaki K. Antiproliferative and anti-invasive effect of piceatannol, a polyphenol present in grapes and wine, against hepatoma AH109A cells. J Biomed Biotechnol. 2012;2012:672416. doi: 10.1155/2012/672416.
   PubMed Web of Science ®Google Scholar
• Kido LA, Hahm E-R, Kim S-H, Baseggio AM, Cagnon VHA, Singh SV, Maróstica MR. Prevention of prostate cancer in transgenic adenocarcinoma of the mouse prostate mice by yellow passion fruit extract and antiproliferative effects of its bioactive compound piceatannol. J Cancer Prev. 2020;25(2):87–99. doi:10.15430/JCP.2020.25.2.87
   PubMedGoogle Scholar
• Li H, Wu WKK, Li ZJ, Chan KM, Wong CCM, Ye CG, Yu L, Sung JJY, Cho CH, Wang M. 2,3’,4,4’,5-Pentamethoxy-trans stilbene, a resveratrol derivative, inhibits colitis-associated colorectal carcinogenesis in mice. Br J Pharmacol. 2010;160(6):1352–61. doi:10.1111/j.1476-5381.2010.00785.x
   PubMedGoogle Scholar
• De Robertis M, Massi E, Poeta ML, Carotti S, Morini S, Cecchetelli L, Signori E, Fazio VM. The AOM/DSS murine model for the study of colon carcinogenesis: from pathways to diagnosis and therapy studies. J Carcinog. 2011;10:9. doi:10.4103/1477-3163.78279
   PubMedGoogle Scholar
• Morris GP, Beck PI, Herridge MS, Depew WT, Szewczuk MR, Wallace JL. Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology. 1989;96(3):795–803. doi:10.1016/S0016-5085(89)80079-4
   PubMed Web of Science ®Google Scholar
• Urruticoechea A, Smith IE, Dowsett M. Proliferation marker Ki-67 in early breast cancer. J Clin Oncol. 2005;23(28):7212–20. doi:10.1200/JCO.2005.07.501
   PubMed Web of Science ®Google Scholar
• Goodson WH, Moore DH, Waldman FM. Ki-67 correlates with in vivo bromodeoxyuridine labeling index in operable breast cancer. 2006;24:3809. doi:10.1200/JCO.2006.07.1209
   Google Scholar
• Maeda T. Nutrition and proliferation of colonic mucosa epithelial cells. J Jpn Soc Colo-Proctol. 1990;43(6):1124–33. doi:10.3862/jcoloproctology.43.1124
   Google Scholar
• Kimura Y, Sumiyoshi M. Anti-tumor and anti-metastatic actions of wogonin isolated from Scutellaria baicalensis roots through anti-lymphangiogenesis. Phytomedicine. 2013;20(3-4):328–36. doi:10.1016/j.phymed.2012.10.016
   PubMed Web of Science ®Google Scholar
• Kimura Y, Sumiyoshi M. Antitumor and antimetastatic actions of dihydroxycoumarins (esculetin or fraxetin) through the inhibition of M2 macrophage differentiation in tumor-associated macrophages and/or G1 arrest in tumor cells. Eur J Pharmacol. 2015;746:115–25. doi:10.1016/j.ejphar.2014.10.048
   PubMed Web of Science ®Google Scholar
• Lewis CE, Pollard JW. Distinct role of macrophages in different tumor microenvironments. Cancer Res. 2006;66(2):605–12. doi:10.1158/0008-5472.CAN-05-4005
   PubMed Web of Science ®Google Scholar
• Joyce JA, Pollard JW. Microenvironmental regulation of metastasis. Nat Rev Cancer. 2009;9(4):239–52. doi:10.1038/nrc2618
   PubMed Web of Science ®Google Scholar
• Sica A, Schioppa T, Mantovani A, Allavena P. Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy . Eur J Cancer. 2006;42(6):717–27. doi:10.1016/j.ejca.2006.01.003
   PubMed Web of Science ®Google Scholar
• Sica A, Larghi P, Mancino A, Rubino L, Porta C, Totaro MG, Rimoldi M, Biswas SK, Allavena P, Mantovani A. Macrophage polarization in tumour progression. Semin Cancer Biol. 2008;18(5):349–55. doi:10.1016/j.semcancer.2008.03.004
   PubMed Web of Science ®Google Scholar
• Okazaki T, Honjo T. The PD-1-PD-L pathway in immunological tolerance . Trends Immunol. 2006;27(4):195–201. doi:10.1016/j.it.2006.02.001
   PubMed Web of Science ®Google Scholar
• Okazaki T, Honjo T. PD-1 and PD-1 ligands: from discovery to clinical application. Int Immunol. 2007;19(7):813–24. doi:10.1093/intimm/dxm057
   PubMed Web of Science ®Google Scholar
• Keir ME, Butte MJ, Freeman GI, Sharpe AH. PD-1 and its ligands in tolerance and immunity. Annu Rev Immunol. 2008;26:677–704. doi:10.1146/annurev.immunol.26.021607.090331
   PubMed Web of Science ®Google Scholar
• Zou W, Wolchok JD, Chen L. PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations. Sci Transl Med. 2016;8(328):328rv4. doi:10.1126/scitranslmed.aad7118
   PubMed Web of Science ®Google Scholar
• Pollard JW. Tumour-educated macrophages promote tumour progression and metastasis . Nat Rev Cancer. 2004;4(1):71–8. doi:10.1038/nrc1256
   PubMed Web of Science ®Google Scholar
• Gordon SR, Maute RL, Dulken BW, Hutter G, George BM, McCracken MN, Gupta R, Tsai JM, Sinha R, Corey D, et al. PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity . Nature. 2017;545(7655):495–501. doi:10.1038/nature22396
   PubMed Web of Science ®Google Scholar
• Yavuz BG, Gunaydin G, Gedik ME, Kosemehmetoglu K, Karakoc D, Ozgur F, Guc D. Cancer associated fibroblasts sculpt tumour microenvironment by recruiting monocytes and inducing immunosuppressive PD-1+ TAMs. Sci Rep. 2019;9(1):3172. doi:10.1038/s41598-019-39553-z
   PubMedGoogle Scholar
• Shawki S, Ashburn J, Signs SA, Huang E. Colon cancer: inflammation-associated cancer. Surg Oncol Clin N Am. 2018;27(2):269–87. doi:10.1016/j.soc.2017.11.003
   PubMed Web of Science ®Google Scholar
• Son P-S, Park S-A, Na H-K, Jue D-M, Kim S, Surh Y-A. Piceatannol, a catechol-type polyphenol, inhibits phorbol ester-induced NF-kappa B activation and cyclooxygenase-2 expression in human breast epithelial cells: cysteine 179 of IKK beta as a potential target. Carcinogenesis. 2010;31(8):1442–9. doi:10.1093/carcin/bgq099
   PubMed Web of Science ®Google Scholar
• Ashikawa K, Majumdar S, Banerjee S, Bharti AC, Shishodia S, Aggarwal BB. Piceatannol inhibits TNF-induced NF-kappaB activation and NF-kappaB-mediated gene expression through suppression of IkappaBalpha kinase and p65 phosphorylation. J Immunol. 2002;169(11):6490–7. doi:10.4049/jimmunol.169.11.6490
   PubMed Web of Science ®Google Scholar